Ken N. Wills
- Molecular Biology top 10%
- Genetics top 2%
- Oncology top 5%
- Biotechnology top 2%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Magnus PfahlXiao-kun ZhangMaty TzukermanGerhart GraupnerThomas HermannDuane E. JohnsonDaniel C. ManevalRichard J. Gregory
- Topics
- Virus-based gene therapy research (12 papers)Cancer Research and Treatments (9 papers)Estrogen and related hormone effects (7 papers)
- Cited by
- BiotechnologyGeneticsOncology
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Ken N. Wills
28 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 1.2k
- Genetics 955
- Oncology 567
- Biotechnology 306
- Endocrinology, Diabetes and Metabolism 226
Countries citing papers authored by Ken N. Wills
This map shows the geographic impact of Ken N. Wills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken N. Wills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken N. Wills more than expected).
Fields of papers citing papers by Ken N. Wills
This network shows the impact of papers produced by Ken N. Wills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken N. Wills. The network helps show where Ken N. Wills may publish in the future.
Co-authorship network of co-authors of Ken N. Wills
This figure shows the co-authorship network connecting the top 25 collaborators of Ken N. Wills. A scholar is included among the top collaborators of Ken N. Wills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken N. Wills. Ken N. Wills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 7 | |
| 3 | 10 | |
| 4 | 27 | |
| 5 | 7 | |
| 6 | 38 | |
| 7 | 33 | |
| 8 | 44 | |
| 9 | 21 | |
| 10 | 56 | |
| 11 | p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer. | 35 |
| 12 | 80 | |
| 13 | 6 | |
| 14 | 204 | |
| 15 | 31 | |
| 16 | 55 | |
| 17 | 21 | |
| 18 | 2 | |
| 19 | 71 | |
| 20 | 274 |
About Ken N. Wills
Ken N. Wills is a scholar working on Biotechnology, Genetics and Oncology, having authored 28 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), Cancer Research and Treatments (9 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Biotechnology (306 citations), Genetics (955 citations) and Oncology (567 citations). Ken N. Wills has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Magnus Pfahl, Xiao-kun Zhang, Maty Tzukerman, Gerhart Graupner, Thomas Hermann, Duane E. Johnson, Daniel C. Maneval, Richard J. Gregory, Suganto Sutjipto and Robert Bookstein. Their work appears in journals such as Nature, Circulation and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.